News
20hon MSN
In study after study, injected GLP-1 weight loss medications appear to work better on average for women than they do for men.
1hon MSN
Research on weight loss drugs like Ozempic shows varied results for mental health impacts, with some patients experiencing ...
22hon MSN
Pharmaceutical company Novo Nordisk, maker of blockbuster weight loss drug Wegovy, says its CEO is stepping down ...
Newer medications, such as Mounjaro and Wegovy, exhibit both more total weight lost and faster weight regain than older ...
The side effects of the two drugs combined include dizziness, abnormal sensations, altered taste, insomnia, constipation and ...
The millions of people living with obesity need novel treatment options that are safe, effective and avoid the high costs and ...
Polycystic ovary syndrome (PCOS) is a complex hormonal condition affecting an estimated eight to 20 percent of women of ...
Novo Nordisk, maker of weight loss drug Wegovy, says CEO Lars Fruergaard Jorgensen is leaving the company by "mutual ...
Lars Fruergaard Jorgensen, who has headed the pharmaceutical company for eight years, will step down after a period to ...
Losing weight after a years-long struggle, this letter writer gave credit to the method — then came the judgmental comments.
Former FDA Commissioner David Kessler shared his experience with GLP-1 weight loss drugs on "CBS Mornings Plus." ...
Jason Kelce weighed 295 lbs. in the NFL before he started his weight loss journey in March 2024. Here's everything Jason ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results